Thus, it is likely that the majority of patients with high-titer of anti-GAD Ab, and not, as yet, any clinical evidence of ataxia, may well have LACA, and that a smaller proportion of patients with low-titer anti-GAD Ab may also have LACA. This evidence concerns the gene GAD1 and Ataxia.